Skip to main content
Article thumbnail
Location of Repository

Statin pre-treatment is associated with lower platelet activity and favorable outcome in patients with acute non-cardio-embolic ischemic stroke

By Nai-Wen Tsai, Tsu-Kung Lin, Wen-Neng Chang, Chung-Ren Jan, Chi-Ren Huang, Shang-Der Chen, Kuei-Yueh Cheng, Yi-Fang Chiang, Hung-Chen Wang, Tzu-Ming Yang, Yu-Jun Lin, Wei-Che Lin, Hsueh-Wen Chang, Lian-Hui Lee and Cheng-Hsien Lu
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2010). AE: Computed tomography in acute ischemic stroke. Neuroradiology
  2. (2002). Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. Circulation
  3. (2010). CH: Serial change in platelet activation markers with aspirin and clopidogrel after acute ischemic stroke. Clin Neuropharmacol
  4. (2009). CH: The value of leukocyte adhesion molecules in patients after ischemic stroke.
  5. (2007). Clinical practice. Acute ischemic stroke.
  6. (2006). Course of platelet activation and plateletleukocyte interaction in cerebrovascular ischemia. Stroke
  7. (1988). Discovery, biochemistry and biology of lovastatin.
  8. (1993). EE: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial.
  9. (2000). Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability. Cardiovasc Res
  10. (2002). F: Time-dependent effect of statins on platelet function in hypercholesterolaemia.
  11. (2005). French WJ: Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality.
  12. (2002). Grau AJ: Course of platelet activation markers after ischemic stroke. Stroke
  13. (2003). JW: Serial measurement of surface expressions of CD63, P-selectin and CD40 ligand on platelets in atherosclerotic ischemic stroke. A possible role of CD40 ligand on platelets in atherosclerotic ischemic stroke. Cerebrovasc Dis
  14. (2007). KM: Effects of intense lowdensity lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke
  15. (2007). Koroshetz WJ: Acute ischemic stroke: overview of recent therapeutic developments. Annu Rev Med
  16. (2004). Lalouschek W: Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events.
  17. (2005). Link between platelet activity and outcomes after an ischemic stroke. Cerebrovasc Dis
  18. (2005). M: HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke
  19. (2004). Martí-Vilalta J-L: Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke
  20. (2002). Platelets in atherothrombosis.
  21. (1998). Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group.
  22. (2008). RJ: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
  23. (2005). Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability. Arterioscler Thromb Vasc Biol
  24. (2002). Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice. Brain Res
  25. (2005). Secondary prevention of recurrent stroke. Stroke
  26. (2007). Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology
  27. (2002). Statins as potent antiinflammatory drugs. Circulation
  28. (2001). Statins inhibit leukocyte recruitment: new evidence for their anti-inflammatory properties. Arterioscler Thromb Vasc Biol
  29. (2002). Statins: the new aspirin? Cell Mol Life Sci
  30. (2006). Tamargo RJ: Inflammation in stroke and focal cerebral ischemia. Surg Neurol
  31. (2009). Tanne D: Prior use of statins improves outcome in patients with intracerebral hemorrhage: prospective data from the National Acute Stroke Israeli Surveys (NASIS). Stroke
  32. (2003). Withdrawal of statin treatment abrogates stroke protection in mice. Stroke
  33. (2006). Yang JQ: Rebound phenomenon of inflammatory response may be a major mechanism responsible for increased cardiovascular events after abrupt cessation of statin therapy. Med Hypotheses

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.